January 16, 2025 - 15:49

Infinium has officially announced the successful completion of its Series C investment round, alongside the acquisition of Greyrock Technology. This significant move is expected to bolster Infinium's position in the market as a leader in ultra-low carbon eFuels. The funding will facilitate the expansion of its innovative production capabilities, enhancing the company's commitment to sustainability and reducing carbon emissions.
The acquisition of Greyrock Technology is particularly noteworthy, as it brings in advanced technology and expertise that will further accelerate Infinium's development of eFuels. With the increasing global demand for cleaner energy solutions, Infinium aims to leverage this strategic acquisition to enhance its product offerings and operational efficiency.
Infinium's eFuels are recognized for their potential to significantly reduce greenhouse gas emissions compared to traditional fuels. The company’s initiatives align with the growing trend towards decarbonization in the energy sector, making this investment a pivotal step in its mission to create a more sustainable future.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...